Evidence map›Paper›PMID 34903185›Full record

ArticleBMC pediatrics2021

When first line treatment of neonatal infection is not enough: blood culture and resistance patterns in neonates requiring second line antibiotic therapy in Bangui, Central African Republic.

Andrea Nebbioso, Oluwakemi F Ogundipe, Ernestina Carla Repetto, Calorine Mekiedje, Hugues Sanke-Waigana, Gilles Ngaya, Brecht Ingelbeen, Julita Gil-Cuesta

Open access · goldAbstract read
In one paragraph

Article in BMC pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Neonatal Paenibacilliosis: Paenibacillus Infection as a Novel Cause of Sepsis in Term Neonates With High Risk of Sequelae in Uganda.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Andrea NebbiosoMédecins Sans Frontières - Operational Centre Brussels (MSF-OCB), Rue de l'Arbre Bénit 46, 1050, Brussels, Belgium. andreanebbioso@gmail.com.
Oluwakemi F OgundipeMédecins Sans Frontières - Operational Centre Brussels (MSF-OCB), Rue de l'Arbre Bénit 46, 1050, Brussels, Belgium.
Ernestina Carla RepettoMédecins Sans Frontières - Operational Centre Brussels (MSF-OCB), Rue de l'Arbre Bénit 46, 1050, Brussels, Belgium.
Calorine MekiedjeMédecins Sans Frontières - Operational Centre Brussels (MSF-OCB), Rue de l'Arbre Bénit 46, 1050, Brussels, Belgium.
Hugues Sanke-WaiganaInstitut Pasteur Bangui, CAR, Bangui, Central African Republic.
Gilles NgayaInstitut Pasteur Bangui, CAR, Bangui, Central African Republic.
Brecht IngelbeenDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Julita Gil-CuestaMédecins Sans Frontières - Operational Centre Brussels (MSF-OCB), Rue de l'Arbre Bénit 46, 1050, Brussels, Belgium.
Médecins Sans Frontières · BEInstitut Pasteur de Bangui · CFInstituut voor Tropische Geneeskunde · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfectious diseases account for the third most common cause of neonatal deaths. Globally, antibiotic resistance (ABR) has been increasingly challenging neonatal sepsis treatment, with 26 to 84% of gram-negative bacteria resistant to third-generation cephalosporins. In sub-Saharan Africa, limited evidence is available regarding the neonatal microbiology and ABR. To our knowledge, no studies have assessed neonatal bacterial infections and ABR in Central-African Republic (CAR). Therefore, this study aimed to describe the pathogens isolated and their specific ABR among patients with suspected antibiotic-resistant neonatal infection admitted in a CAR neonatal unit.

methodsThis retrospective cohort study included neonates admitted in the neonatal unit in Bangui, CAR, from December 2018 to March 2020, with suspected antibiotic-resistant neonatal infection and subsequent blood culture. We described the frequency of pathogens isolated from blood cultures, their ABR prevalence, and factors associated with fatal outcome.

resultsBlood cultures were positive in 33 (26.6%) of 124 patients tested (17.9% for early-onset and 46.3% for late-onset infection; p = 0.002). Gram-negative bacteria were isolated in 87.9% of positive samples; with most frequently isolated bacteria being Klebsiella pneumoniae (39.4%), Escherichia coli (21.2%) and Klebsiella oxytoca (18.2%). All tested bacteria were resistant to ampicillin. Resistance to third-generation cephalosporins was observed in 100% of tested Klebsiella pneumoniae, 83.3% of isolated Klebsiella oxytoca and 50.0% of tested Escherichia coli. None of the tested bacteria were resistant to carbapenems. Approximately 85.7 and 77.8% of gram-negative tested bacteria were resistant to first-line (ampicillin-gentamicin) and second-line (third-generation cephalosporins) treatments, respectively. In hospital mortality, adjusted for blood culture result, presence of asphyxia, birth weight and sex was higher among neonates with positive blood culture (adjusted relative risk [aRR] = 2.32; 95% confidence interval [CI] = 1.17-4.60), male sex (aRR = 2.07; 95% CI = 1.01-4.26), asphyxia (aRR = 2.42; 95% CI = 1.07-5.47) and very low birth weight (1000-1499 g) (aRR = 2.74; 95% CI = 1.3-5.79).

conclusionOverall, 77.8% of confirmed gram-negative neonatal infections could no longer effectively be treated without broad-spectrum antibiotics that are not routinely used in sub-Saharan Africa referral hospitals. Carbapenems should be considered an option in hospitals with surveillance and antibiotic stewardship.

Indexed as

Blood CultureCommunicable DiseasesAnti-Bacterial AgentsCentral African RepublicDrug Resistance, BacterialHumansInfant, NewbornMaleMicrobial Sensitivity TestsRetrospective StudiesAnti-Bacterial AgentsAntibiotic resistanceBlood cultureCentral-African RepublicEscherichia coliGram-negative bacteriaKlebsiellaNeonatal infectionNeonatal intensive care unitNeonatal sepsisSub-Saharan Africa.

Identifiers

PMID34903185
PMCPMC8667452
OpenAlexW4200567858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.